COVID-19

Showing 15 posts of 602 posts found.

covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

August 12, 2020
Research and Development COVID-19, coronavirus, covid news

The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …

fda

Gilead applies for FDA approval to treat coronavirus patients with remdesivir

August 11, 2020
Manufacturing and Production COVID-19, Gilead, coronavirus

Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients. The drug would go under …

vxxxxeer

Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine

August 11, 2020
Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus

President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …

droxtchcc

Over 100 Americans have died after taking hydroxychloroquine in the first half of 2020

August 10, 2020
Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine

More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus. This was found in …

vxxxxeer

Over a third of Americans say they won’t take a coronavirus vaccine

August 10, 2020
Sales and Marketing COVID-19, coronavirus, vaccines

35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling. A new Gallup …

novavax

Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions

August 10, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine

Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …

vaccination-1215279_960_720

Early promise from Novavax’s vaccine candidate for COVID-19

August 7, 2020
Medical Communications, Research and Development COVID-19, Novavax, Vaccine

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …

astrazeneca_building_white

AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China

August 7, 2020
Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, China, pharma

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 7, 2020
Medical Communications COVID-19, Top 10 news, top 10

The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …

j_and_j

US to pay Johnson and Johnson $1 billion for COVID-19 vaccine

August 6, 2020
Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus

The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …

800px-nhs_nnuh_entrance

NICE advises GPs to stop prescribing opioids for chronic pain

August 5, 2020
Business Services, Research and Development COVID-19, coronavirus

The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …

covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

August 5, 2020
Research and Development COVID-19, Weekly round up, coronavirus

The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …

eu_flag

EU agrees deal with Sanofi for COVID-19 vaccine supply

August 3, 2020
Sales and Marketing COVID, COVID-19, coronavirus

The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow …

covid_test

England to start using two new 90-minute COVID-19 tests in preparation for the winter

August 3, 2020
Sales and Marketing COVID-19, coronavirus

Two new coronavirus tests are set to be made available throughout England that are significantly faster than most already in …

shutterstock_138095450

US Government commits $2.1bn to GSK and Sanofi’s COVID-19 vaccine candidate

July 31, 2020
Medical Communications, Research and Development COVID-19, GSK, Sanofi, US, Vaccine

The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the …

The Gateway to Local Adoption Series

Latest content